Trexquant Investment LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$1,967,000
+605.0%
92,947
+375.6%
0.12%
+582.4%
Q4 2018$279,000
-71.5%
19,545
-58.4%
0.02%
-77.0%
Q3 2018$978,000
+228.2%
46,972
+272.6%
0.07%
+252.4%
Q2 2018$298,000
-73.3%
12,605
-84.2%
0.02%
-92.5%
Q3 2017$1,117,000
+336.3%
79,923
+175.7%
0.28%
+301.4%
Q2 2017$256,00028,9840.07%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders